Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterations 2024-10-24 15:15
Founder of Hua Medicine Dr. Li CHEN was awarded the "C.C. Tan Life Science Industrialization Award" 2024-10-24 13:16
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation 2024-10-24 08:08
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent 2024-10-24 06:02
Caliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat Reduction 2024-10-24 01:42
CCTV+: Explore the Wizard of Oz in Jiangzhong Pharmaceutical Valley 2024-10-23 15:38
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals 2024-10-22 18:57
Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in "Kidney 360" Magazine 2024-10-22 07:40
Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia 2024-10-21 22:20
Everest Medicines Announces Taiwan TFDA Approval of NEFECON® for the Treatment of Primary IgA Nephropathy 2024-10-21 07:40
Hong Kong Breast Cancer Foundation "Pink Walk 2024" Charity Walk Concluded Successfully 2024-10-20 17:23
Xinhua Silk Road: 55th Zhangshu National Traditional Chinese Materia Medica Trade Fair held in E. China's Jiangxi 2024-10-18 20:23
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings 2024-10-18 14:42
Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country 2024-10-18 10:35
Telix Files Form 20-F Registration Statement for Nasdaq ADS 2024-10-18 05:32
Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M 2024-10-17 15:54
Cambrex Opens New Stability Storage Facility in Durham, North Carolina 2024-10-17 15:00
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy 2024-10-17 14:30
IND Application for a Phase Ⅲ Clinical Study of KN026 Combined with Albumin-bound Docetaxel as Neoadjuvant Treatment for Breast Cancer was Approved 2024-10-17 10:15
Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Ulcerative Colitis Met Primary Endpoint 2024-10-17 08:00
1 2 3 4 5 6 247